Prevention of ocular scarring post glaucoma filtration surgery using the inflammatory cell and platelet binding modulator saratin in a rabbit model

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Min, Jeff ^a   Lukowski, Zachary L ^a   Levine, Monica A ^a   Meyers, Craig A ^a   Beattie, Ashley R ^a   Schultz, Gregory S ^a   Samuelson, Don A ^b   Sherwood, Mark B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; COLLAGEN; MITOMYCIN C; SARATIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; MITOMYCIN; SALIVA PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL DENSITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FIBROBLAST; GLAUCOMA FILTRATION SURGERY; GLAUCOMA SURGERY; GOBLET CELL; HISTOPATHOLOGY; INFLAMMATORY CELL; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; INTRAOPERATIVE PERIOD; NEUTROPHIL; NONHUMAN; OCULAR SCARRING; POSTOPERATIVE PERIOD; SCAR FORMATION; WOUND HEALING; ANIMAL; DISEASE MODEL; DRUG EFFECT; EYE; FIBROSIS; FILTERING OPERATION; GLAUCOMA; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; PATHOLOGY; RABBIT; SCAR; THROMBOCYTE; THROMBOSIS; TOPICAL DRUG ADMINISTRATION;

ORYCTOLAGUS CUNICULUS;

ADMINISTRATION, TOPICAL; ANIMALS; BLOOD PLATELETS; CICATRIX; DISEASE MODELS, ANIMAL; EYE; FIBROSIS; FILTERING SURGERY; GLAUCOMA; HUMANS; INJECTIONS, INTRAOCULAR; MITOMYCIN; RABBITS; SALIVARY PROTEINS AND PEPTIDES; THROMBOSIS;

EID: 84860460483     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035627     Document Type: Article

References (29)

1. Burr J, Azuara-Blanco A, Avenell A, (2005) Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev 18: CD004399.
2. DeBry PW, Perkins TW, Heatley G, et al. (2002) Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 120: 297-300.
3. Muckley ED, Lehrer RA, (2004) Late-onset blebitis/endophthalmitis: incidence and outcomes with mitomycin C. Optom Vis Sci 81: 499-504.
4. Francis BA, Du LT, Najafi K, Murthy R, Kurumety U, et al. (2005) Histopathologic features of conjunctival filtering blebs. Arch Ophthalmol 123: 166-70.
5. Li Z, Van Bergen T, Van de Veire S, Van de Vel I, Moreau H, et al. (2009) Inhibition of vascular endothelial growth factor reduces scar formation after glaucoma filtration surgery. Invest Ophthal Vis Sci 50: 5217-5225.
6. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, et al. (2002) Efficacy and safety of mitomycin-C in primary trabeculectomy: five year follow-up. Ophthalmology 109: 1336-1341.
7. Anand N, Arora S, Clowes M, (2006) Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol. 90: 175-180.
8. Beckers HJ, Kinders KC, Webers CA, (2003) Five-year results of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Opthalmol 241: 106-10.
9. Denk PO, Hoppe J, Hoppe V, Knorr M, (2003) Effect of growth factors on the activation of human Tenon's capsule fibroblasts. Curr Eye Res 27: 35-44.
10. Schultz G, Khaw PT, Oxford K, MaCauley S, Van Setten G, et al. (1994) Growth factors and ocular wound healing. Eye 8: 184-187.
11. Khaw PT, Occleston NL, Schultz G, Grierson I, Sherwood MB, et al. (1994) Activation and suppression of fibroblast function. Eye 8: 188-195.
12. Meyer-ter-Vehn T, Katzenberger B, Han H, Grehn F, Schlunck G, (2008) Lovastatin inhibits TGF-β-induced myofibroblast transdifferentiation in human tenon fibroblasts. Invest Ophthal Vis Sci 49: 3955-3960.
13. Xiao YQ, Liu K, Shen JF, Xu G, Ye W, (2009) SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Invest Ophthal Vis Sci 50: 1698-1706.
14. Barnes CS, Krafft B, Frech M, Hofmann UR, Papendieck A, (2001) Production and characterization of saratin, an inhibitor of von Willebrand factor-dependent platelet adhesion to collagen. Semin Thromb Hemost 24: 337-348.
15. Bonnefoy A, Romijn RA, Vandervoort PA, VAN Rompaey I, Vermylen J, et al. (2006) Von Willebrand factor A1 domain can adequately substitute for A3 domain in recruitment of flowing platelets to collagen. J Thromb Taemost 4: 2151-61.
16. White TC, Berny MA, Robinson DK, Yin H, DeGrado WF, et al. (2007) The leech product saratin is a potent inhibitor of platelet integrin alpha2beta1 and von Willebrand factor binding to collagen. FEBS J 274: 1481-1491.
17. Gronwald W, Bomke J, Maurer T, Domogalla B, Huber F, et al. (2008) Structure of the leech protein saratin and characterization of its binding to collagen. J Mol Biol 381: 913-927.
18. Smith TP, Alshafie TA, Cruz CP, Fan CY, Brown AT, et al. (2003) Saratin, an inhibitor of collagen-platelet interaction, decreases venous anastomotic intimal hyperplasia in a canine dialysis access model. Vasc Endovascular Surg 37: 259-69.
19. Davis JA, Brown AT, Alshafie T, Poirier LA, Cruz CP, et al. (2004) Saratin (an inhibitor of platelet-collagen interaction) decreases platelet aggregation and homocysteine-mediated postcarotid endarterectomy intimal hyperplasia in a dose-dependent manner. Am J Surg 188: 778-785.
20. Vilahur G, Duran X, Juan-Babot O, Casani L, Badimon L, (2004) Antithrombotic effects of saratin on human atherosclerotic plaques. Thromb Haemost 95: 191-200.
21. Dugrillon A, Eichler H, Kern S, Kluter H, (2002) Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration. Int J Oral Maxillofac Surg 31: 615-9.
22. Glidden PF, (2010) Methods and compositions for blocking platelet and cell adhesion, cell migration and inflammation. Patent No.
23. Gehring S, Hoerauf H, Laqua H, Kirchner H, Kluter H, (1999) Preparation of autologous platelets for the ophthalmic treatment of macular holes. Transfusion 39: 144-148.
24. Knorr M, Volker M, Denk PO, Wunderlich K, Thiel HJ, (1997) Proliferative response of cultured human Tenon's capsule fibroblasts to platelet-derived growth factor isoforms. Graefe's Arch Clin Exp Ophthalmol 235: 667-671.
25. Cordeiro MF, Constable PH, Alexander RA, Bhattacharya SS, Khaw PT, (1997) Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 38: 1639-1646.
26. Sherwood MB, Esson DW, Neelakantan A, Samuelson DA, (2004) A new model of glaucoma filtering surgery in the rat. J Glaucoma 13: 407-12.
27. Doyle JW, Sherwood MB, Khaw PT, McGrory S, Smith MF, (1993) Intraoperative 5-fluorouracil for filtration surgery in the rabbit. Invest Ophthalmol Vis Sci 34: 3313-3319.
28. Connon CJ, Meek KM, (2003) Organization of corneal collagen fibrils during the healing of trephined wounds in rabbits. Wound Repair Regen 11: 71-78.
29. Khaw PT, Doyle JW, Sherwood MB, Smith MF, McGorray S, (1993) Effects of intraoperative 5-fluorouracil or mitomycin C on glaucoma filtration surgery in the rabbit. Ophthalmology100: 367-72.